DiaMedica Therapeutics appointed Julie Krop as Chief Medical Officer, succeeding Lorianne Masuoka.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
DiaMedica Therapeutics appointed Julie Krop as Chief Medical Officer, succeeding Lorianne Masuoka.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
PureTech Ventures
american company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireDiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer MINNEAPOLIS, August 06, 2025--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical